Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2021

Open Access 01-12-2021 | Research article

Comparison of prevalence of diabetes complications in Brazilian and Mexican adults: a cross-sectional study

Authors: Renata Breda Martins, Sandra Azucena Ordaz-Briseño, Sarahí Flores-Hernández, Ângelo José Gonçalves Bós, Raúl C. Baptista-Rosas, Arieh Roldán Mercado-Sesma

Published in: BMC Endocrine Disorders | Issue 1/2021

Login to get access

Abstract

Background

Type 2 diabetes is more frequent in Latin American people than in non-Hispanic whites due to a combination of genetic and lifestyle risk factors. Brazil and Mexico are the most populous countries in Latin America. The present study aimed to compare the results of the National Health Survey “PNS” in Brazil and the National Survey Health and Nutrition “ENSANUT” in Mexico regarding the prevalence, complications and healthcare issues of diabetes in both countries.

Methods

A cross-sectional study was conducted with data from the National Health Survey (PNS) of 2013 in Brazil and the National Survey of Health and Nutrition (ENSANUT) of 2018 in Mexico. The prevalence of diabetes, complications and risk factors related to developing diabetes were considered.

Results

The respondents included 3636 individuals in Brazil and 4555 individuals in Mexico. There were significant differences in age and time living with diabetes between the two countries. Mexican people had twice as likely as Brazilian people to have a complication (p < 0.0001). The principal risk factor (OR 2.47; p ≤ 0.0001) for developing any diabetic complication was living with diabetes for more than 15 years. Visual impairment was the most frequent complication in both countries, but it was more prevalent in Mexico (p ≤ 0.001).

Conclusions

Diabetes complications are important health problems in Brazil and Mexico. Visual impairment was the principal complication in both countries. Several factors, such as access to and type of health system, living in a rural area, treatment, BMI and performing preventive actions, affected the risk of developing a complication. However, living with diabetes for more than 15 years was the principal risk factor. National health surveys have added significant information on the impact of diabetes in these Latin American populations. This comparison of data could provide valuable information to guide national policies and program decisions in both countries.
Literature
1.
go back to reference International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels: International Diabetes Federation; 2017. International Diabetes Federation. IDF Diabetes Atlas. 8th ed. Brussels: International Diabetes Federation; 2017.
2.
go back to reference Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2011. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2011.
4.
go back to reference United Nations. Department of economic and social affairs, population division. In: World population prospects: the 2017 revision, Volume I: Comprehensive tables; 2017. United Nations. Department of economic and social affairs, population division. In: World population prospects: the 2017 revision, Volume I: Comprehensive tables; 2017.
5.
go back to reference American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033–46.CrossRef American Diabetes Association. Economic Costs of Diabetes in the U.S. in 2012. Diabetes Care. 2013;36(4):1033–46.CrossRef
8.
go back to reference The World Health Organization. Assessing National Capacity for the Prevention and Control of Non–communicable Diseases. Washington D.C: Report of the Americas Region; 2013. December 2013 The World Health Organization. Assessing National Capacity for the Prevention and Control of Non–communicable Diseases. Washington D.C: Report of the Americas Region; 2013. December 2013
10.
go back to reference Norma Oficial Mexicana. NOM-015-SSA2-2010, Para la prevención, tratamiento y control de la diabetes mellitus. 2010. Norma Oficial Mexicana. NOM-015-SSA2-2010, Para la prevención, tratamiento y control de la diabetes mellitus. 2010.
15.
go back to reference García-Chapa EG, Leal-Ugarte E, Peralta-Leal V, Durán-González J, Meza-Espinoza JP, et al. Biomed Res Int. 2017;ID 3937893:10. García-Chapa EG, Leal-Ugarte E, Peralta-Leal V, Durán-González J, Meza-Espinoza JP, et al. Biomed Res Int. 2017;ID 3937893:10.
17.
go back to reference Rusu V, Hoch E, Mercader JM, Tenen DE, Gymrek M, Hartigan CR, DeRan M, von Grotthuss M, Fontanillas P, Spooner A, Guzman G, Deik AA, Pierce KA, Dennis C, Clish CB, Carr SA, Wagner BK, Schenone M, Ng MCY, Chen BH, Centeno-Cruz F, Zerrweck C, Orozco L, Altshuler DM, Schreiber SL, Florez JC, Jacobs SBR, Lander ES, Ng MCY, Shriner D, Chen BH, Li J, Chen WM, Guo X, Liu J, Bielinski SJ, Yanek LR, Nalls MA, Comeau ME, Rasmussen-Torvik LJ, Jensen RA, Evans DS, Sun YV, An P, Patel SR, Lu Y, Long J, Armstrong LL, Wagenknecht L, Yang L, Snively BM, Palmer ND, Mudgal P, Langefeld CD, Keene KL, Freedman BI, Mychaleckyj JC, Nayak U, Raffel LJ, Goodarzi MO, Chen YDI, Taylor HA Jr, Correa A, Sims M, Couper D, Pankow JS, Boerwinkle E, Adeyemo A, Doumatey A, Chen G, Mathias RA, Vaidya D, Singleton AB, Zonderman AB, Igo RP Jr, Sedor JR, Kabagambe EK, Siscovick DS, McKnight B, Rice K, Liu Y, Hsueh WC, Zhao W, Bielak LF, Kraja A, Province MA, Bottinger EP, Gottesman O, Cai Q, Zheng W, Blot WJ, Lowe WL, Pacheco JA, Crawford DC, Grundberg E, Rich SS, Hayes MG, Shu XO, Loos RJF, Borecki IB, Peyser PA, Cummings SR, Psaty BM, Fornage M, Iyengar SK, Evans MK, Becker DM, Kao WHL, Wilson JG, Rotter JI, Sale MM, Liu S, Rotimi CN, Bowden DW, Mercader JM, Huerta-Chagoya A, García-Ortiz H, Moreno-Macías H, Manning A, Caulkins L, Burtt NP, Flannick J, Patterson N, Aguilar-Salinas CA, Tusié-Luna T, Altshuler D, Florez JC, Martínez-Hernández A, Centeno-Cruz F, Barajas-Olmos FM, Zerrweck C, Contreras-Cubas C, Mendoza-Caamal E, Revilla-Monsalve C, Islas-Andrade S, Córdova E, Soberón X, Orozco L, González-Villalpando C, González-Villalpando ME, Haiman CA, Wilkens L, le Marchand L, Monroe K, Kolonel L, Arellano-Campos O, Ordóñez-Sánchez ML, Rodríguez-Torres M, Segura-Kato Y, Rodríguez-Guillén R, Cruz-Bautista I, Muñoz-Hernandez LL, Sáenz T, Gómez D, Alvirde U, Almeda-Valdés P, Cortes ML. Type 2 diabetes variants disrupt function of SLC16A11 through two distinct mechanisms. Cell. 2017;170(1):199–212. https://doi.org/10.1016/j.cell.2017.06.011.CrossRefPubMedPubMedCentral Rusu V, Hoch E, Mercader JM, Tenen DE, Gymrek M, Hartigan CR, DeRan M, von Grotthuss M, Fontanillas P, Spooner A, Guzman G, Deik AA, Pierce KA, Dennis C, Clish CB, Carr SA, Wagner BK, Schenone M, Ng MCY, Chen BH, Centeno-Cruz F, Zerrweck C, Orozco L, Altshuler DM, Schreiber SL, Florez JC, Jacobs SBR, Lander ES, Ng MCY, Shriner D, Chen BH, Li J, Chen WM, Guo X, Liu J, Bielinski SJ, Yanek LR, Nalls MA, Comeau ME, Rasmussen-Torvik LJ, Jensen RA, Evans DS, Sun YV, An P, Patel SR, Lu Y, Long J, Armstrong LL, Wagenknecht L, Yang L, Snively BM, Palmer ND, Mudgal P, Langefeld CD, Keene KL, Freedman BI, Mychaleckyj JC, Nayak U, Raffel LJ, Goodarzi MO, Chen YDI, Taylor HA Jr, Correa A, Sims M, Couper D, Pankow JS, Boerwinkle E, Adeyemo A, Doumatey A, Chen G, Mathias RA, Vaidya D, Singleton AB, Zonderman AB, Igo RP Jr, Sedor JR, Kabagambe EK, Siscovick DS, McKnight B, Rice K, Liu Y, Hsueh WC, Zhao W, Bielak LF, Kraja A, Province MA, Bottinger EP, Gottesman O, Cai Q, Zheng W, Blot WJ, Lowe WL, Pacheco JA, Crawford DC, Grundberg E, Rich SS, Hayes MG, Shu XO, Loos RJF, Borecki IB, Peyser PA, Cummings SR, Psaty BM, Fornage M, Iyengar SK, Evans MK, Becker DM, Kao WHL, Wilson JG, Rotter JI, Sale MM, Liu S, Rotimi CN, Bowden DW, Mercader JM, Huerta-Chagoya A, García-Ortiz H, Moreno-Macías H, Manning A, Caulkins L, Burtt NP, Flannick J, Patterson N, Aguilar-Salinas CA, Tusié-Luna T, Altshuler D, Florez JC, Martínez-Hernández A, Centeno-Cruz F, Barajas-Olmos FM, Zerrweck C, Contreras-Cubas C, Mendoza-Caamal E, Revilla-Monsalve C, Islas-Andrade S, Córdova E, Soberón X, Orozco L, González-Villalpando C, González-Villalpando ME, Haiman CA, Wilkens L, le Marchand L, Monroe K, Kolonel L, Arellano-Campos O, Ordóñez-Sánchez ML, Rodríguez-Torres M, Segura-Kato Y, Rodríguez-Guillén R, Cruz-Bautista I, Muñoz-Hernandez LL, Sáenz T, Gómez D, Alvirde U, Almeda-Valdés P, Cortes ML. Type 2 diabetes variants disrupt function of SLC16A11 through two distinct mechanisms. Cell. 2017;170(1):199–212. https://​doi.​org/​10.​1016/​j.​cell.​2017.​06.​011.CrossRefPubMedPubMedCentral
20.
go back to reference Schaan AP, Costa L, Santos D, Modesto A, Amador M, Lopes C, Rabenhorst SH, Montenegro R, Souza BDA, Lopes T, et al. mtDNA structure: the women who formed the Brazilian Northeast. BMC Evol Biol. 2017;17(1):185.CrossRef Schaan AP, Costa L, Santos D, Modesto A, Amador M, Lopes C, Rabenhorst SH, Montenegro R, Souza BDA, Lopes T, et al. mtDNA structure: the women who formed the Brazilian Northeast. BMC Evol Biol. 2017;17(1):185.CrossRef
23.
go back to reference Gedebjerg A, Almdal TP, Berencsi K, Rungby J, Nielsen JS, Witte DR, Friborg S, Brandslund I, Vaag A, Beck-Nielsen H, Sørensen HT, Thomsen RW. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: a cross-sectional baseline study of 6958 patients in the Danish DD2 cohort. J Diabetes Complicat. 2018;32(1):34–40. https://doi.org/10.1016/j.jdiacomp.2017.09.010.CrossRef Gedebjerg A, Almdal TP, Berencsi K, Rungby J, Nielsen JS, Witte DR, Friborg S, Brandslund I, Vaag A, Beck-Nielsen H, Sørensen HT, Thomsen RW. Prevalence of micro- and macrovascular diabetes complications at time of type 2 diabetes diagnosis and associated clinical characteristics: a cross-sectional baseline study of 6958 patients in the Danish DD2 cohort. J Diabetes Complicat. 2018;32(1):34–40. https://​doi.​org/​10.​1016/​j.​jdiacomp.​2017.​09.​010.CrossRef
24.
go back to reference Peters SAE, Woodward M. Sex differences in the burden and complications of diabetes. Curr Diab Rep. 2018;13:33.CrossRef Peters SAE, Woodward M. Sex differences in the burden and complications of diabetes. Curr Diab Rep. 2018;13:33.CrossRef
26.
go back to reference Price AJ, Crampin AC, Amberbir A, Kayuni-Chihana N, Musicha C, Tafatatha T, Branson K, Lawlor DA, Mwaiyeghele E, Nkhwazi L, Smeeth L, Pearce N, Munthali E, Mwagomba BM, Mwansambo C, Glynn JR, Jaffar S, Nyirenda M. Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi. Lancet Diabetes Endocrinol. 2018;6(3):208–22. https://doi.org/10.1016/S2213-8587(17)30432-1.CrossRefPubMedPubMedCentral Price AJ, Crampin AC, Amberbir A, Kayuni-Chihana N, Musicha C, Tafatatha T, Branson K, Lawlor DA, Mwaiyeghele E, Nkhwazi L, Smeeth L, Pearce N, Munthali E, Mwagomba BM, Mwansambo C, Glynn JR, Jaffar S, Nyirenda M. Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi. Lancet Diabetes Endocrinol. 2018;6(3):208–22. https://​doi.​org/​10.​1016/​S2213-8587(17)30432-1.CrossRefPubMedPubMedCentral
29.
go back to reference Yaribeygi H, Butler AE, Sahebkar A. Aerobic exercise can modulate the underlying mechanisms involved in the development of diabetic complications. J Cell Physiol. 2019;234(8):12508–15. Yaribeygi H, Butler AE, Sahebkar A. Aerobic exercise can modulate the underlying mechanisms involved in the development of diabetic complications. J Cell Physiol. 2019;234(8):12508–15.
35.
go back to reference UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–53.CrossRef
37.
go back to reference American Diabetes Association. 9. Pharmacologic Approaches to glycemic treatment: Standards of medical care in diabetes. Diabetes Care. 2019;42(Suppl 1):S90–S102.CrossRef American Diabetes Association. 9. Pharmacologic Approaches to glycemic treatment: Standards of medical care in diabetes. Diabetes Care. 2019;42(Suppl 1):S90–S102.CrossRef
38.
go back to reference Yurgin NR, Boye KS, Dilla T, Suriñach NL, Llach XB. Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain. Patient Prefer Adherence. 2008;2:87–95. Yurgin NR, Boye KS, Dilla T, Suriñach NL, Llach XB. Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain. Patient Prefer Adherence. 2008;2:87–95.
39.
go back to reference Luis-Emilio García-Pérez, María Álvarez, Tatiana Dilla, Vicente Gil-Guillén, Domingo Orozco-Beltrán, Adherence to Therapies in Patients with Type 2 Diabetes. Diabetes Therapy. 2013;4(2):175–94. Luis-Emilio García-Pérez, María Álvarez, Tatiana Dilla, Vicente Gil-Guillén, Domingo Orozco-Beltrán, Adherence to Therapies in Patients with Type 2 Diabetes. Diabetes Therapy. 2013;4(2):175–94.
40.
go back to reference The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. New England J Med. 1993;329(14):977–86. The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus. New England J Med. 1993;329(14):977–86.
41.
go back to reference Koppes LLJ, Dekker JM, Hendriks HFJ, Bouter LM, Heine RJ. Moderate Alcohol Consumption Lowers the Risk of Type 2 Diabetes: A metaanalysis of prospective observational studies. Diab Care. 2005;28(3):719–25. Koppes LLJ, Dekker JM, Hendriks HFJ, Bouter LM, Heine RJ. Moderate Alcohol Consumption Lowers the Risk of Type 2 Diabetes: A metaanalysis of prospective observational studies. Diab Care. 2005;28(3):719–25.
42.
go back to reference Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, Rehm J. Alcohol as a Risk Factor for Type 2 Diabetes: A systematic review and meta-analysis. Diabetes Care. 2009;32(11):2123–32. Baliunas DO, Taylor BJ, Irving H, Roerecke M, Patra J, Mohapatra S, Rehm J. Alcohol as a Risk Factor for Type 2 Diabetes: A systematic review and meta-analysis. Diabetes Care. 2009;32(11):2123–32.
43.
go back to reference Hendriks HFJ. Moderate Alcohol Consumption and Insulin Sensitivity: Observations and Possible Mechanisms. Ann Epidemiol. 2007;17(5):S40–2. Hendriks HFJ. Moderate Alcohol Consumption and Insulin Sensitivity: Observations and Possible Mechanisms. Ann Epidemiol. 2007;17(5):S40–2.
44.
go back to reference Takao T, Ide T, Yanagisawa H, Kikuchi M, Kawazu S, Matsuyama Y. The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients. Diabetes Res Clin Pract. 2011;91(2):e40–2. Takao T, Ide T, Yanagisawa H, Kikuchi M, Kawazu S, Matsuyama Y. The effects of fasting plasma glucose variability and time-dependent glycemic control on the long-term risk of retinopathy in type 2 diabetic patients. Diabetes Res Clin Pract. 2011;91(2):e40–2.
Metadata
Title
Comparison of prevalence of diabetes complications in Brazilian and Mexican adults: a cross-sectional study
Authors
Renata Breda Martins
Sandra Azucena Ordaz-Briseño
Sarahí Flores-Hernández
Ângelo José Gonçalves Bós
Raúl C. Baptista-Rosas
Arieh Roldán Mercado-Sesma
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2021
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-021-00711-y

Other articles of this Issue 1/2021

BMC Endocrine Disorders 1/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.